首页> 外文期刊>Journal of medical imaging and radiation oncology >Splenic scintigraphy for further differentiation of unclear Ga-68-DOTATOC-PET/CT findings: Strengths and limitations
【24h】

Splenic scintigraphy for further differentiation of unclear Ga-68-DOTATOC-PET/CT findings: Strengths and limitations

机译:脾闪烁显像术进一步区分不清楚的Ga-68-DOTATOC-PET / CT结果:优势和局限性

获取原文
获取原文并翻译 | 示例
       

摘要

Splenic scintigraphy has been described to be a powerful tool in unclear Ga-68-DOTATOC-PET/CT findings, allowing differentiation between somatostatin receptor ( Sst)-positive tissue deriving from neuroendocrine tumour ( NET) and functioning splenic tissue. However, our own experiences sometimes show a lack of identification on splenic scintigraphy, especially in small lesions, leading to uncertainties regarding the safe identification of NET or splenic tissue. Here, we report on 10 cases with Ga-68-DOTATOC-PET/CT and Tc-99m-heat-denaturated red blood cell ( HDRBC) scintigraphy and we illustrate the strengths and limitations of Tc-99m-HDRBC scintigraphy in this context.
机译:脾闪烁显像术已被描述为在不清楚的Ga-68-DOTATOC-PET / CT发现中的有力工具,可以区分源自神经内分泌肿瘤(NET)的生长抑素受体(Sst)阳性组织与功能性脾脏组织。然而,我们自己的经验有时显示在脾闪烁显像术上缺乏识别,尤其是在小病变中,导致对NET或脾组织安全鉴定的不确定性。在此,我们报道了10例Ga-68-DOTATOC-PET / CT和Tc-99m热变性红细胞(HDRBC)闪烁显像的病例,并说明了Tc-99m-HDRBC闪烁显像的优势和局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号